Trial Profile
A Study Comparing Dopamine D3 and D2 Receptor Occupancies in Healthy Subjects Treated with a Single Dose of Blonanserin Using a Positron Emission Tomography with [11C]-(+)-PHNO
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jan 2018
Price :
$35
*
At a glance
- Drugs Blonanserin (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics
- 23 Jan 2018 New trial record
- 13 Jan 2018 Results published in the International Journal of Neuropsychopharmacology.